SOURCE: annual_report_text (1).txt
CHUNK: 700 of 1106
SIZE: 591 characters
PREVIOUS: chunk_0699_annual_report_text (1).txt
NEXT: chunk_0701_annual_report_text (1).txt
------------------------------
conversion with a high 
delivery volume and a solid order intake 
in H1; === Page 131 ===
IBA Annual Report 2023 
128. revenues for the Dosimetry segment of EUR 
65.9 million, a strong 22.1% increase from 
2022 (2022: EUR 54.0 million) from organic 
and external growth following the acquisition 
of Modus in 2022. For the year-ended December 31, 2023, the 
Group 
gross 
margin 
(31.4%) 
worsened 
compared to 2022 (35.1%) following inflation 
and lower overhead absorption. The previous 
year performance was also positively impacted 
by indemnities related to the Rutherfords 
bankruptcy.